Developing a strategy to define the effects of insulin-like growth factor-1 on gene expression profile in cardiomyocytes

Circulation Research

Volumn 88, Issue 12, 2001, Pages 1231-1238

  Liu, Tsun Jui ^a,b   Lai, Hui Chin ^a,b   Wu, Weihua ^a   Chinn, Steven ^a   Wang, Ping H ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac muscle; Gene expression; Insulin like growth factor; Mitogen activated protein kinase; Phosphatidylinositol 3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL FUNCTION; CELL SURVIVAL; DNA MICROARRAY; ENZYME INHIBITION; ENZYME REGULATION; GENE CLUSTER; GENE EXPRESSION REGULATION; GENETIC REGULATION; HEART MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 0035933363     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh1201.092036     Document Type: Article

References (35)

1. Changes of IGF I system in acute myocardial infarction: Implications on left ventricular remodeling
2. Insulin-like growth factor I as a cardiac hormone: Physiological and pathophysiological implications in heart disease
3. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses
4. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I
5. The transcriptional program in the response of human fibroblasts to serum
6. High throughput analysis of differential gene expression
7. Expression of constitutively active phosphatidylinositol 3 kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells
8. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
9. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray
10. Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1
11. Altered patterns of gene expression in response to myocardial infarction
12. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes
13. Casein kinase 2 as a potentially important enzyme in the nervous system
14. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins
15. The Pezcoller lecture: Cancer cell cycles revisited
16. Cardiac hypertrophy: Signal transduction, transcriptional adaptation, and altered growth control
17. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice
18. Mitochondria and heart disease
19. Cardiomyopathies in disorders of oxidative metabolism
20. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart: An age-related phenomenon: A histochemical ultracytochemical study
21. Abnormal mitochondrial function in myocardium of dogs with chronic heart failure
22. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I
23. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway: Divergence from downstream CT-1 signals for myocardial cell hypertrophy
24. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1
25. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in established canine cardiomyopathy
26. Overexpression of insulin-likegrowth factor I in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy
27. 2+ through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles
28. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways
29. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-I receptor
30. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
31. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
32. Up-regulated expression of plasminogen activator inhibitor-1 in Hep G2 cells: Interrelationship between insulin and insulin-like growth factor 1
33. CAP defines a second signalling pathway required for insulin-stimulated glucose transport
34. Synergistic role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase cascade in the regulation of insulin receptor trafficking
35. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways